Europe active pharmaceutical ingredients (API) market was valued at $ 49.4 billion in 2022 and will grow by 6.8% annually over 2022-2032, driven by rising adoption of biologics in disease management, increasing regulatory approvals, patent expiration of major drugs, growing trend of outsourcing and increase in geriatric population.
Highlighted with 91 tables and 76 figures, this 198-page report "Europe Active Pharmaceutical Ingredients (API) Market 2022-2032 by Molecule (Small, Large), Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity" is based on a comprehensive research of the entire Europe active pharmaceutical ingredients (API) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe active pharmaceutical ingredients (API) market in every aspect of the classification from perspectives of Molecule, Synthesis, Manufacturing Process, Therapeutic Application, Drug Type, and Country.
Based on Molecule, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Small Molecule APIs
• Large Molecule APIs
Based on Synthesis, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Synthetic API
o Branded Synthetic API
o Generic Synthetic API
• Biotech API
o by type
Monoclonal Antibodies
Recombinant Proteins
Vaccines
Other Biotech APIs
o by Category
Innovative Biologic API
Generic Biosimilar API
o by Expression
Mammalian Expression
Microbial Expression
Yeast Expression
Insect Expression
Other Expression Technologies
• HPAPI
o Branded HPAPI
o Generic HPAPI
Based on Manufacturing Process, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Captive Manufacturing
o Branded Captive API
o Generic Captive API
• Merchant Manufacturing
o by Drug Type
Branded Merchant API
Generic Merchant API
o by Drug Synthesis
Merchant Synthetic API
Merchant Biotech API
By Therapeutic Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Infectious Diseases
• Oncology
• Ophthalmology
• Cardiovascular Disorders
• Central Nervous System
• Pulmonary Disorders
• Orthopedics
• Other Applications
By Drug Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Branded Prescription Drugs
• Generic Prescription Drugs
• OTC Drugs
Geographically, the following national/local markets are fully investigated:
• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2032. The breakdown of national markets by Synthesis, Manufacturing Process, and Therapeutic Application over the forecast years are also included.
The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
AbbVie Inc.
Astrazeneca
Aurobindo Pharma Ltd.
BASF
Bayer AG
Boehringer Ingelheim
Catalent Inc.
Dr. Reddy's Laboratories
F. Hoffmann-La Roche
GlaxoSmithKline plc
Lonza Group
Lupin Limited
Merck & Co., Inc.
Mylan NV
Novartis International AG
Pfizer Inc.
Sanofi
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Thermo Fisher Scientific
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 25
2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery 32
2.2 Major Growth Drivers 36
2.3 Market Restraints and Challenges 44
2.4 Emerging Opportunities and Market Trends 47
2.5 Porter's Fiver Forces Analysis 51
3 Segmentation of Europe Market by Molecule 55
3.1 Market Overview by Molecule 55
3.2 Small Molecule APIs 57
3.3 Large Molecule APIs 58
4 Segmentation of Europe Market by Synthesis 59
4.1 Market Overview by Synthesis 59
4.2 Synthetic API 61
4.2.1 Branded Synthetic API 62
4.2.2 Generic Synthetic API 63
4.3 Biotech API 64
4.3.1 Biotech API by Drug Type 65
4.3.1.1 Monoclonal Antibodies 66
4.3.1.2 Recombinant Proteins 67
4.3.1.3 Vaccines 68
4.3.1.4 Other Biotech APIs 69
4.3.2 Biotech API by Category 70
4.3.2.1 Innovative Biologic API 71
4.3.2.2 Generic Biosimilar API 72
4.3.3 Biotech API by Expression Technology 73
4.3.3.1 Mammalian Expression 74
4.3.3.2 Microbial Expression 75
4.3.3.3 Yeast Expression 76
4.3.3.4 Insect Expression 77
4.3.3.5 Other Expression Technologies 78
4.4 HPAPI 79
4.4.1 Branded HPAPI 80
4.4.2 Generic HPAPI 81
5 Segmentation of Europe Market by Manufacturing Process 82
5.1 Market Overview by Manufacturing Process 82
5.2 Captive Manufacturing 84
5.2.1 Branded Captive API 85
5.2.2 Generic Captive API 86
5.3 Merchant Manufacturing 87
5.3.1 Merchant Manufacturing by Drug Type 88
5.3.1.1 Branded Merchant API 89
5.3.1.2 Generic Merchant API 90
5.3.2 Merchant Manufacturing by Drug Synthesis 91
5.3.2.1 Merchant Synthetic API 92
5.3.2.2 Merchant Biotech API 93
6 Segmentation of Europe Market by Therapeutic Application 94
6.1 Market Overview by Therapeutic Application 94
6.2 Infectious Diseases 96
6.3 Oncology 97
6.4 Ophthalmology 98
6.5 Cardiovascular Disorders 99
6.6 Central Nervous System 100
6.7 Pulmonary Disorders 101
6.8 Orthopedics 102
6.9 Other Applications 103
7 Segmentation of Europe Market by Drug Type 104
7.1 Market Overview by Drug Type 104
7.2 Branded Prescription Drugs 106
7.3 Generic Prescription Drugs 107
7.4 OTC Drugs 108
8 European Market 2022-2032 by Country 109
8.1 Overview of European Market 109
8.2 UK 112
8.3 France 114
8.4 Germany 116
8.5 Spain 119
8.6 Italy 121
8.7 Russia 123
8.8 Rest of European Market 125
9 Competitive Landscape 127
9.1 Overview of Key Vendors 127
9.2 New Product Launch, Partnership, Investment, and M&A 130
9.3 Company Profiles 131
AbbVie Inc. 131
Astrazeneca 133
Aurobindo Pharma Ltd. 138
BASF 141
Bayer AG 144
Boehringer Ingelheim 148
Catalent Inc. 153
Dr. Reddy's Laboratories 156
F. Hoffmann-La Roche 158
GlaxoSmithKline plc 161
Lonza Group 166
Lupin Limited 170
Merck & Co., Inc. 173
Mylan NV 176
Novartis International AG 179
Pfizer Inc. 182
Sanofi 187
Sun Pharmaceutical Industries Ltd. 190
Teva Pharmaceutical Industries Ltd. 193
Thermo Fisher Scientific 195
Related Reports and Products 198
Market Overview
The Europe Banking as a Service (BaaS) Market is set to experience significant growth from 2024 to 2034, driven by the rapid digital transformation of the financial sector, the increasing adoption of embedded finance solutions, and the rising demand for seamless customer...
Market Overview
The Europe Perfume Packaging Market is poised for substantial growth from 2024 to 2034, fueled by rising consumer demand for premium fragrances, evolving aesthetic preferences, and the growing emphasis on sustainable packaging solutions. The market is projected to achiev...
Market Overview
The Europe Alternate Marine Power (AMP) Market is set to witness remarkable growth from 2024 to 2034, driven by stringent environmental regulations, increasing adoption of green maritime technologies, and the pressing need to reduce greenhouse gas (GHG) emissions in the ...
Market Overview
The Europe Bio Vanillin Market is poised for significant growth from 2024 to 2034, driven by rising consumer preference for natural and sustainable food ingredients, stringent regulatory measures against synthetic additives, and increasing applications in diverse industr...
Market Overview
The Europe AI-Enabled Biometric Market is expected to experience substantial growth from 2024 to 2034, driven by the rising demand for enhanced security systems, increasing adoption of artificial intelligence (AI) technologies, and the need for more efficient biometric i...
Market Overview
The Europe Commercial Vehicle Telematics Market is set to experience robust growth from 2024 to 2034, driven by the increasing adoption of connected technologies, enhanced fleet management solutions, and the need for real-time data analytics across commercial vehicle ope...
Market Overview
The Europe Passive Optical Network (PON) Market is anticipated to experience significant growth from 2024 to 2034, driven by the increasing demand for high-speed internet, data services, and the transition towards fiber-based broadband solutions. As fiber-optic networks ...
Market Overview
The Europe Safety Valves Market is projected to witness steady growth from 2024 to 2034, driven by rising demand across critical industries such as oil and gas, energy and power, and water treatment. With increased focus on safety and regulatory compliance, the market is...
The Freeze-drying Pharmaceutical Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufa...
The Active RFID Asset Management Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufa...